Tempest Therapeutics Inc
Change company Symbol lookup
Select an option...
TPST Tempest Therapeutics Inc
PETV PetVivo Holdings Inc
KMI Kinder Morgan Inc
NXPL NextPlat Corp
D Dominion Energy Inc
CVS CVS Health Corp
CVI CVR Energy Inc
CTRE CareTrust REIT Inc
CSWC Capital Southwest Corp
CSCO Cisco Systems Inc
Go

Health Care : Biotechnology |
Company profile

Tempest Therapeutics, Inc. (Tempest) is a clinical-stage oncology company. The Company is focused on developing small molecules that combine both tumor-targeted and immune-mediated mechanisms with the potential to treat a range of tumors. The Company’s two clinical programs include TPST-1120 and TPST-1495. TPST-1120 is a selective antagonist of peroxisome proliferator-activated receptor alpha (PPARa). TPST-1120 is in Phase I and II trials in solid tumors, including a global randomized Phase Ib/II trial in combination with the standard-of-care first-line regimen of atezolizumab and bevacizumab in patients with advanced or metastatic hepatocellular carcinoma (HCC). Its second clinical program, TPST-1495, a dual antagonist of the EP2 and EP4 receptors of prostaglandin E2, and is in Phase I monotherapy and combination trials in solid tumors.

Closing Price
$1.85
Day's Change
-0.20 (-9.76%)
Bid
--
Ask
--
B/A Size
--
Day's High
2.04
Day's Low
1.76
Volume
(Heavy Day)
Volume:
142,808

10-day average volume:
64,949
142,808

Honeywell International Inc. Stock Rises Tuesday, Still Underperforms Market

4:59 pm ET March 21, 2023 (MarketWatch)
Print

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Honeywell International Inc. (HON) inched 0.67% higher to $191.16 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 1.30% to 4,002.87 and the Dow Jones Industrial Average rising 0.98% to 32,560.60. This was the stock's second consecutive day of gains. Honeywell International Inc. closed $29.80 short of its 52-week high ($220.96), which the company achieved on November 25th.

The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as General Electric Co. (GE) rose 2.51% to $92.18, 3M Co. (MMM) fell 0.02% to $104.29, and Johnson Controls International PLC (JCI) rose 1.93% to $59.67. Trading volume (3.1 M) remained 184,277 below its 50-day average volume of 3.3 M.

Data source: Dow Jones Market Data, FactSet. Data compiled March 21, 2023.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

	

(END) Dow Jones Newswires

March 21, 2023 16:59 ET (20:59 GMT)

Copyright (c) 2023 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.